MedInvest Oncology 
Investor Conference

December 7-10, 2021

TAKING PLACE
December 7-10, 2021
Virtually

Access the 
Partnering System
(on November 23)

150+ Investors
45-50 Presenting Companies
8-10 Keynotes and Panels
Virtual Partnering System
One-on-One Meetings

ABOUT THE VIRTUAL MEDINVEST ONCOLOGY INVESTOR CONFERENCE 

The upcoming semiannual meeting of the MedInvest Oncology Investor Conference Series will be held on December 7-10, 2021. The conference will feature 2 days of livestream with company presentations and keynote talks, and 4 days of one-on-one meetings. The partnering system will be open for one full month.

The event is the preeminent investment conference in the oncology space. The attendees are investors seeking to invest in private and public cancer companies, and oncology-focused companies seeking investment.  The meetings of the Oncology Investor Conference have been held twice a year since 2017.

​

The National Cancer Institute is the Presenting Partner.  Oncology Investor Conference Series sponsors include Perkins Coie, Cooley Law Firm, McDermitt, Will & Emery Law Firm, Venable Law Firm, Freemind Consultants, Torreya Partners and Marcum.

Join the leading life science and oncology venture capitalists, family offices, lawyers, pharma executives, startup public and private cancer companies and cancer foundations for a discussion on trends, opportunities and risks in oncology investing. 

Oncology-experienced CRO. 95% client repeat rate, industry-best timelines & decentralized capabilities.

Research consultancy that exclusively offers pro bono services to inventors of preclinical stage lung and pancreatic cancer technologies

Presenting Partner